Feb 062017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– CANADA, VIctoria – Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced its Board of Directors has appointed Dr.… => Read more

Aurinia Pharmaceuticals names Dr Richard Glickman to additional role of CEO

From:: Aurinia Pharmaceuticals names Dr Richard Glickman to additional role of CEO

Sorry, the comment form is closed at this time.

%d bloggers like this: